Skip to main content

Klein Joseph III's Form 4 filing

Ionis Pharmaceuticals Inc (IONS) · filed Jul 19, 2023

Accession no.
0000874015-23-000176
Filed
Jul 19, 2023
Trade date
Jul 17-18, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $149.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klein Joseph IIICIK 0001206369Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 17, 2023Common StockMOption exerciseAcquired+1,777$0.00$018,568Direct
Jul 17, 2023Common StockMOption exerciseAcquired+5,333$0.00$023,901Direct
Jul 18, 2023Common StockSSaleDisposed−3,555$42.00−$149,31020,346Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 17, 2023Common StockMOption exerciseDisposed−1,777$0.00$010,010Direct
Jul 17, 2023Common StockMOption exerciseDisposed−5,333$0.00$04,677Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)